Results 271 to 280 of about 157,097 (332)
Expression and prognosis of CXCL13 in uterine corpus endometrial carcinoma based on bioinformatics analysis. [PDF]
Wang Z, Gao Y.
europepmc +1 more source
SNX24 serves as a potential prognostic biomarker and a therapeutic target in uterine corpus endometrial carcinoma according to bioinformatics and experimentations. [PDF]
Long D, Fan X, Zhu Y.
europepmc +1 more source
Unveiling <i>PIK3CA</i> mutation: a prognostic beacon in endometrial carcinoma and its immune implications. [PDF]
Cao S +7 more
europepmc +1 more source
The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting. [PDF]
Wang Y +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Annual Review of Pathology: Mechanisms of Disease, 2007
Endometrial carcinoma, a common malignancy of the female genital tract, is composed of a number of tumor types with different light-microscopic features, molecular genetic alterations, and prognoses. In addition, hormonal influences significantly impact growth regulatory pathways and interact with genetic alterations in the pathogenesis of at least ...
Antonio, Di Cristofano +1 more
+7 more sources
Endometrial carcinoma, a common malignancy of the female genital tract, is composed of a number of tumor types with different light-microscopic features, molecular genetic alterations, and prognoses. In addition, hormonal influences significantly impact growth regulatory pathways and interact with genetic alterations in the pathogenesis of at least ...
Antonio, Di Cristofano +1 more
+7 more sources
Current Treatment Options in Oncology, 2001
Endometrial cancer is a common tumor of the female genital tract. The majority of women diagnosed with endometrial cancer present with early-stage disease. Although the optimal treatment for these patients requires hysterectomy, the use of lymphadenectomy is controversial.
W K, Huh +3 more
openaire +2 more sources
Endometrial cancer is a common tumor of the female genital tract. The majority of women diagnosed with endometrial cancer present with early-stage disease. Although the optimal treatment for these patients requires hysterectomy, the use of lymphadenectomy is controversial.
W K, Huh +3 more
openaire +2 more sources
Vanishing Endometrial Carcinoma
International Journal of Gynecological Pathology, 2007Three cases of histologically proven endometrial carcinoma (EmCa) demonstrated no residual carcinoma or biopsy site on the subsequent hysterectomy specimen. The shared identity of both endometrial biopsy and hysterectomy specimen was proven, and specimen misidentification was excluded in all 3 cases through successful DNA profiling.
Valérie, Dubé +4 more
openaire +2 more sources
Nonendometrioid endometrial carcinomas
Seminars in Diagnostic Pathology, 2010Clinicopathologic studies support a classification of endometrial carcinoma into two main categories (type I and type II). Type I cancers consist of endometrioid and mucinous carcinomas, with the former being the most common, whereas serous and clear cell carcinomas are the so-called "prototype" of type II cancers.
Diana, Lim, Esther, Oliva
openaire +2 more sources

